Everolimus 10mg Tablets from Japan
Everolimus is an mTOR inhibitor used as an antineoplastic for renal cell carcinoma and immunosuppressive for transplant rejection, in 10mg film-coated tablets. Classified in HTS 3004.90.92.16 for dosed immunosuppressive medicaments.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Reference Orange Book patent status to determine generic import eligibility
• Ensure moisture-proof packaging documentation for hygroscopic APIs